GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individualâs nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļWGS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļGeneDx Holdings Corp
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 04, 2020
āļāļĩāļāļĩāđāļStueland (Katherine A)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ1000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 04
āļāļĩāđāļāļĒāļđāđ333 Ludlow Street
āđāļĄāļ·āļāļSTAMFORD
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ06902
āđāļāļĢāļĻāļąāļāļāđ18887291206
āđāļ§āđāļāđāļāļāđhttps://sema4.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļWGS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 04, 2020
āļāļĩāļāļĩāđāļStueland (Katherine A)
Global X Genomics & Biotechnology ETF
Franklin Genomic Advancements ETF
State Street SPDR S&P Health Care Services ETF
Innovator IBD Breakout Opportunities ETF
ARK Genomic Revolution ETF
Main Thematic Innovation ETF
Invesco Dorsey Wright Healthcare Momentum ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Global X Genomics & Biotechnology ETF
āļŠāļąāļāļŠāđāļ§āļ3.84%
Franklin Genomic Advancements ETF
āļŠāļąāļāļŠāđāļ§āļ3.47%
Clough Hedged Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.89%
Clough Select Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.65%
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļāļŠāđāļ§āļ2.27%
Harbor Health Care ETF
āļŠāļąāļāļŠāđāļ§āļ1.85%
Innovator IBD Breakout Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ1.52%
ARK Genomic Revolution ETF
āļŠāļąāļāļŠāđāļ§āļ1.29%
Main Thematic Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
āļŠāļąāļāļŠāđāļ§āļ1.18%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ